Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

AXGN

Axogen (AXGN)

Axogen Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AXGN
일자시간출처헤드라인심볼기업
2024/05/1620:00GlobeNewswire Inc.Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
2024/05/1420:00GlobeNewswire Inc.Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads ConferenceNASDAQ:AXGNAxogen Inc
2024/05/0220:00GlobeNewswire Inc.Axogen, Inc Reports First Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
2024/04/3005:50GlobeNewswire Inc.Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
2024/04/1620:00GlobeNewswire Inc.Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:AXGNAxogen Inc
2024/03/0907:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
2024/03/0907:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
2024/03/0906:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
2024/03/0808:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
2024/03/0806:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
2024/03/0622:59Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
2024/03/0622:53Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AXGNAxogen Inc
2024/03/0622:45Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AXGNAxogen Inc
2024/03/0606:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
2024/03/0606:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
2024/03/0521:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
2024/03/0521:00GlobeNewswire Inc.Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial ResultsNASDAQ:AXGNAxogen Inc
2024/02/2406:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
2024/02/2406:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
2024/02/2406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
2024/02/1505:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
2024/02/1406:30GlobeNewswire Inc.Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024NASDAQ:AXGNAxogen Inc
2024/02/1303:21Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXGNAxogen Inc
2024/02/0707:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
2024/02/0306:15GlobeNewswire Inc.Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
2024/02/0223:29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
2024/01/2701:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
2024/01/1907:00GlobeNewswire Inc.Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve CapNASDAQ:AXGNAxogen Inc
2024/01/1207:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
2024/01/1207:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
 검색 관련기사 보기:NASDAQ:AXGN